Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population
2018 · Lipids in Health and Disease · 18 citations
https://doi.org/10.1186/s12944-018-0859-5
L
Li Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
897
Citations
15
h-index
17
i10-index
Li Li is an academic researcher from Beihua University. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Protease and Inhibitor Mechanisms & Health Systems, Economic Evaluations, Quality of Life. The author has an h-index of 15, co-authored 31 publications.
ORCID: 0000-0001-6005-2679Papers by this author
worksA New Strategy for Rapidly Screening Natural Inhibitors Targeting the PCSK9/LDLR Interaction In Vitro
2018 · Molecules · 15 citations
https://doi.org/10.3390/molecules23092397
LDL-cholesterol lowering agents (statins and PCSK9 inhibitors) and the risk of intracerebral hemorrhage: A network meta-analysis
2025 · Journal of Stroke and Cerebrovascular Diseases · 5 citations
https://doi.org/10.1016/j.jstrokecerebrovasdis.2025.108224
The Effects of Visual Art Therapy on Improving Anxiety Symptoms in Adults: A Systematic Review and Meta‐Analysis
2025 · Journal of Psychiatric and Mental Health Nursing · 4 citations
https://doi.org/10.1111/jpm.70003
Puerarin improves MASLD by remodeling intestinal microenvironment to promote mitochondrial fusion and autophagy
2025 · Journal of Pharmacological Sciences · 3 citations
https://doi.org/10.1016/j.jphs.2025.03.001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat